Response to the randomized trial of recombinant human erythropoietin in critically ill patients.
Belova
Eva
E
Kanna
Balavenkatesh
B
D018806:APACHE; D000368:Aged; D000740:Anemia / Q000517:prevention & control*; D016638:Critical Illness; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000097:blood; D011994:Recombinant Proteins
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron